ࡱ>  G\p Bean, Emily Ba= =*X)d8X@"1*k MS Sans Serif1*k MS Sans Serif1*k MS Sans Serif1*k MS Sans Serif1*k MS Sans Serif1* k MS Sans Serif1*k MS Sans Serif1kArial1kArial1kArial1*k MS Sans Serif1kArial1kArial1kArial1kArial1kArial1*k MS Sans Serif1kArial1kArial1kArial1kArial1kArial1kArial1QkTahoma1kArial1kArial1kArial1Calibri1 Calibri1Calibri14Calibri1 Calibri1Arial1Calibri1Calibri1,8Calibri18Calibri18Calibri1>Calibri14Calibri1<Calibri1?Calibri1h8Cambria1Calibri1 Calibri1Arial1Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_) "$"#,##0.00mmmm\ d\,\ yyyy94_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"??_);_(@_)$[$-409]dddd\,\ mmmm\ dd\,\ yyyy[$-409]h:mm:ss\ AM/PM 0.0% d\-mmm\-yyyy"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)0.0,'[$$-409]#,##0.00_);\([$$-409]#,##0.00\) 0.000%                                                                      ff + ) , * , !, ,  , , , , "  #  $ P % P &  &  '   ( ` )    !            *         + , a> -    "|@ @  "|@ @  "0@ @  H "x@ @    *x@ @ "8@ @ *x@ @    `@ @  xf@ @ xaf@ @  *x!@ @  *x@ "t@ "t@ "t@  "t@  "t!@  *x@ @ "t@ @ "t!@ @  x!@ @ "t!@ @ (pa@ @  ` .8 .8""@ @  .8"@ @  |@ |@ <@ <@ |!@ .8"@ @  |@ @  |@ @ |@ @  |!@ @  |@ @  |!@ @  .8"!@ @  |!@ @ <!@ @  ??v9]#,##0.̙[$ -##0.  }A}? }9]#,##0.[$ -}A}@ e9]#,##0.[$ -}-}B 9]#,##0.}(}C 9]#,##0.}x}K9]#,##0.[$##  }}L ???9]#,##0.[$???## ???  ??? ???}-}T 9]#,##0.}U}U 9]#,##0.[$## }-}V 9]#,##0.}(}i9]#,##0.}(}j9]#,##0.}(}s 9]#,##0.}(}t 9]#,##0.}(}u 9]#,##0.}(}{ 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(}9]#,##0.}(}9]#,##0.}(}9]#,##0.}(}9]#,##0.}(}9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0.}(} 9]#,##0. 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/ Currency 20 Currency 31 Currency 42 Currency 53 Currency 64 Currency 75 Currency 8* Currency 86Explanatory TextG5Explanatory Text %7 : Followed Hyperlink 8Good;Good  a%9 Heading 1G Heading 1 I}%O: Heading 2G Heading 2 I}%?; Heading 3G Heading 3 I}%23< Heading 49 Heading 4 I}%=( Hyperlink >InputuInput ̙ ??v% ? Linked CellK Linked Cell }% @NeutralANeutral  e%"Normal ANormal 2B Normal 2 2; Normal 2 2 % CNormal 32Normal 3  DNormal 4 ENormal 5 FNormal 6 GNormal 7 HNormal 8&Normal 8INormal_enclosure 5JNormal_enclosure 6 KNoteb Note   LOutputwOutput  ???%????????? ???M$PercentN Percent 2O Percent 3P Percent 4Q Percent 5R Percent 6S Percent 7( Percent 7 TTitle1Title I}% UTotalMTotal %OOV Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`^ enclosure 1 enclosure 2n enclosure 3 enclosure 4 enclosure 5 enclosure 6H kCopy of UPDATED HIV shell date FFY 2018 July-August-September 2018 dated November 7th 2018 ShellDY16Q3.xls InstructionsTotal Costs November 7 2018Sheet2Particip updatedrevisedtoDY16Q4Monitoring Assessment 09-30-18CMS64C FFY2018 Q4 downloadExp Target amountsExpansionDY16 Q3MedicaidDY16Q3Sheet1YYYYYYZ~cSA&]A@dFYA@pSA@]A@ ^AA]AUA@ؤ\A@QY]A]A@%z_A aAaA`aA cAYYYY 2 Contact_Data_R1_Crosstab;  =  =ffpP @zr8=3 A@@  YhIncomingOutgoing AdherenceAmbulance/TransportationCase Management Services Compliance EligibilityERIntroductory CallLaboratory/X-ray MedicationsOtherOut Dated ContactPharmacyPhone Call Follow UpPolicyProvider Services Unpaid Claim Viral Loads'Enclosure 5: Contact Tracking by ReasonContact ReasonTotal ContactsCollaboration Care coordination,Enclosure 6: Contact Tracking by Method Used Method UsedCallEmailFaxLetterFamily Planning%ADAP Funds Spent on MaineCare Clients Member Survey;Maine HIV/AIDS: Overall Service Costs by Demonstration YearDate Submitted to CMS:Quarter Report Period:0Population Group(s) (as identified in the MBES)Total Demo Year Costs ExpansionMedicaid-Actual Participation by Demonstration QuarterDemonstration Year 1:7/01/02 - 6/30/03 Quarter 1 Quarter 2 Quarter 3 Quarter 4Population Group(s) 7/01/02 - 9/30/0210/01/02 - 12/31/021/01/03 - 3/31/034/01/03 - 6/30/03Total Demo Year ParticipationDemonstration Year 2:7/1/03 - 6/30/047/01/03 - 9/30/0310/01/03 - 12/31/031/01/04 - 3/31/044/01/04 - 6/30/04Demonstration Year 3:7/01/04 - 6/30/057/01/04 - 9/30/0410/01/04 - 12/31/041/01/05 - 3/31/054/01/05 - 6/30/05Total Demo Year ParticpationDemonstration Year 4:7/1/05 - 6/30/067/01/05 - 9/30/0510/01/05 - 12/31/051/01/06 - 3/31/064/01/06 - 6/30/06Demonstration Year 5:7/1/06 - 6/30/077/01/06 - 9/30/0610/01/06 - 12/31/061/01/07 - 3/31/074/01/07 - 6/30/07Total Demo Year PartcipationDemonstration Year 6:7/1/07 - 6/30/087/01/07 - 9/30/0710/01/07 - 12/31/071/01/08 - 3/31/084/01/08 - 6/30/08Demonstration Year 7:7/1/08 - 6/30/097/01/08 - 9/30/0810/01/08 - 12/31/081/01/09 - 3/31/094/01/09 - 6/30/09Demonstration Year 8:7/1/09 - 6/30/107/01/09 - 9/30/0910/01/09 - 12/31/091/01/10 - 3/31/104/01/10 - 6/30/10Demonstration Year 9:7/1/10 - 6/30/117/01/10 - 9/30/1010/01/10 - 12/31/101/01/11 - 3/31/114/01/11 - 6/30/11Demonstration Year 10:7/1/11 - 6/30/127/01/1 - 9/30/1110/01/11 - 12/31/111/01/12 - 3/31/124/01/12 - 6/30/12Budget Neutrality Assessment 3(This page automatically calculates entered data.) Annual AssessmentTotal Computable CeilingCumulative Expenditure TargetsCosts Over/Under TargetDemonstration Year 117/1/12 - 6/30/137/01/12 - 9/30/1210/01/12 - 12/31/121/01/13 - 3/31/134/01/13 - 6/30/13 Total Demo Year Partcipation YTDMental Health/Substance Abuse Quarter 57/01/13 - 9/30/1310/01/13 - 12/31/131/01/14 - 3/31/144/01/14 - 6/30/14 Quarter 6Demonstration Year 1201/01/14 - 12/31/14Demonstration Year 11 plus7/1/13 - 12/31/13Expansion <=100% FPLExpansion >100% FPLExpansion Unknown FPLFEDERAL DOLLARS STATE DOLLARSDemonstration Populations0Average ADAP Expenditures for Prescription Drugs.Total ADAP Expenditures for Prescription Drugs&Average ADAP Expenditures for Premiums$Total ADAP Expenditures for Premiums3Average ADAP Expenditures for Copay Reimbursement1Total ADAP Expenditures for Copay Reimbursement InpatientDemonstration Year 1301/01/15 - 12/31/151/01/15 - 3/31/154/01/15 - 6/30/157/01/15 - 9/30/1510/01/15 - 12/31/15MBES (Federal Fiscal Year) DY - 1 FFY: 10/01/02 - 9/30/03DY - 2 FFY: 10/01/03 - 9/30/04DY - 3 FFY: 10/01/04 - 9/30/05DY - 4 FFY: 10/01/05 - 9/30/06DY - 5 FFY: 10/01/06 - 9/30/07DY - 6 FFY: 10/01/07 - 9/30/08DY - 7 FFY: 10/01/08 - 9/30/09DY - 8 FFY: 10/01/09 - 9/30/10DY - 9 FFY: 10/01/10 - 9/30/11DY - 10 FFY: 10/01/11 - 9/30/12DY - 11 FFY: 10/01/12 - 9/30/13DY - 12 FFY: 10/01/13 - 9/30/14DY - 13 FFY: 10/1/14 - 09/30/15Demonstration Year 1401/01/16 - 12/31/161/01/16 - 3/31/164/01/16 - 6/30/167/01/16 - 9/30/1610/01/16 - 12/31/16DY - 14 FFY: 10/1/15 - 09/30/16DY - 13: 1/1/15 - 12/31/15DY - 14: 1/1/16 - 12/31/16N/ADY - 15: 1/1/17 - 12/31/17DY - 15 FFY: 10/1/16 - 09/30/17Total Demo CostsNote - FFY15 Q2 (Waiver DY 12 2014): Updated the "Annual Expenditure Targets" with the figures provided in an email from CMS forwarded by Emily Bean on 5/20/015$ 7/01/14 - 9/30/1410/01/14 - 12/31/14Demonstration Year 1501/01/17 - 12/31/171/01/17 - 3/31/174/01/17 - 6/30/177/01/17 - 9/30/1710/01/17 - 12/31/17 ReadmissionFFY 201801/01/18 - 12/31/181/01/18 - 3/31/184/01/18 - 6/30/187/01/18 - 9/30/1810/01/18 - 12/31/18DY - 16 FFY: 10/1/17 - 09/30/18DY - 16: 1/1/18 - 12/31/18Demonstration Year 16Date: 11/07/2018Date: 11/17/20187/1/2018 - 9/30/2018;  Enrollees at or below 100% FPL: Demonstration  Enrollees  !1:6  Enrollees above 100% FPL: Demonstration  Enrollees  2  Members : HIV Positive and MaineCare eligible!July 1, 2018 - September 30, 2018I IJJKKDSLLLM3N,NO=P6PQaRZ S S |Tu U qVj yWrdX]!YlZe[[ccB G r~  dMbP?_*+%&?'?(?)?MOMS-CT4APRRCMP5054-1  odXX10DR7f SxxuSr! ?!4iсG##>7N@E+ Ƀ ,CH w/;XjD@ B2PН72*ʌ#Α,qJMLXSH=oxb@=o (g 3lDC!g 4pzgG$v5b[pi!4h)!0t:jʋG)Q}u@-TwJ#F~?>]B(]o)^̼PX} К׮fJbsQh%١^# \uߦ5#nry$}dKGWk*Fe8[L8)جabOS0յnA u'-"72kE`b"bۋe+QЦ庌rsRy-ٺuUWE\_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn")XX333333?333333?&<3U} q}  ,0 0 ,0@I@ +@      l" m" rr  d d d d(rr n(b c c c c c c c c  c  c  c  c  d d d d eo fp~ g"`%gHrADcA%gI}AD`mfA%g|AD`;iA%g ADqkA%hAD_`A%hӒAD fA%h;A D *AkA% hLA DSeA& hܣYA D kA& h0uӠA D 5uA& hf`A D `3hA if`AD if`AD if`ADjf`ADkf`A D lm~cSA Zm&]AZm@dFYA Zm@pSAZm@]AZm@ ^AZmA]AZ mUAZ  m@ؤ\AZ  m@QY]A Z  m]A Z  m@%z_A Z m aA ZmaA Zm`aAZm cAZ#n7A  %nn oq! pK DD* pzaW %D* p{e%D* ptr %D* p@x %D* p`y %D* poo} %D* p( %D* p% D * p % D * p(D % D * p,& % D * p( % D * pS %D* pR؃ %D* p`!~ %D" p`!~ DD( (  &  " 44 \,:U ,,8"  PH0(  >@" ggD G %  dMbP?_*+%&?'?(?)?MOMS-CT4APRRCMP5054-1  odXX10DRAC:xuSAr0 =ĝ&m DBӿdɍ].% F] \/(>^5h8BodBU GB U9_ۊ0Xd#lbfVZHU1ʸ BlIs# r& Bp 0NF4R@wTv5$,JV$t%58D7}Q&($9+E dهʭVWlKY(?=ŋy7#d`?浫y,Xdg)jla3]vȨ[>Kպ&}X68b{-3ҍ^U2"G)-*fAYj K6ߙ]=5+F4>ٚ4jrO^0BoDfžzYQІ2rsRyɺuE;WD\=txSn0s*nRR=2:X^Ҫ^o Fq13;O*A;*=dhc(6)lEt% $ NzK]Kz_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn"7XX333333?333333?&<3U} }  } } }  %\h 0t0 ,0  0  0 h \\\  $ !" "       d d d d& # c c c c c c c c c c c c d d d d $ %f De*AX>6.(C:Aa,:E6V/$1_:JfJ#  )A  %   q&f bm,XA  t[jBrN^(OARL5 qNAz[# deA  %  # ~cSA  %  &]A    - @dFYA   @pSA   @]A   @ ^A   A]A   UA  # @ؤ\A  %  @QY]A   ]A   @%z_A   aA   aA   `aA    cA   7A ,rrr,r** (rrrrrrrrrrrrrrr*rrrrrrrrrrrrrrrrrr*rr****rrrrrrrrrrrrrrrrr*rrrrrrrrrrrrrrr*rr****rrrrrrrrrrrrrrrrrr*rrrrrrrrrrrrrrrrrB X6 08.L*:00..:............ !"#$* rr*!*"*#*$rrrrrrrrrrrrrrrrrrJP....   rPH 0(  >@ ggD G  t~fx  dMbP?_*+%&ffffff?'ffffff?(?)?MOMS-CT4APRRCMP5054-1  odXX10DR!̘Y xuSAr0 =ĝ&m DBӿdɍ]- F] \/(3#÷}$4j"@AwqȄ(7hr$·aPF"ح교cq?p%,3P˹?N'n t283'R%veƨ9 daW T+1!0:u 5E#X)8H c>Un rҘg~?>>]B(M)^̻! КמIŖ()[_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn"FXX333333?333333?&<3U} } t              '  ( ) * + , - . / 0 1 2 3 %$S@@V@[@\@`@ &$n@ o@o@o@r@ 4 5 * + , - . 6 7 8 9 3 %$ ^@@_@a@@a@d@ &$ o@o@o@o@r@ : ; * + , - . < = > ? @ %$`@@`@d@g@`g@ &$p@q@s@`s@t@ A B * + , - . C D E F 3 %$e@@j@ l@`o@q@ &$ps@Ps@s@@t@v@ G H * + , - . I J K L M %$pp@0q@p@Pt@v@ &$s@r@p@p@pw@:8T668T668T668T668T6 ! "#$ &' ()* ,- ./0 23 456 89 :;< >? N O !* !+ !, !- ". "P "Q "R "S "M #%$#r@s@`s@ s@w@ $&$$ o@pp@Pp@p@t@ &T &U '* '+ ', '- (. (V (W (X (Y (M )%$)t@ s@s@t@x@ *&$* r@0q@q@p@u@ ,Z ,[ -* -+ -, -- .. .\ .] .^ ._ .M /%$/@u@u@ v@v@z@ 0&$0p@p@q@s@v@ 2` 2a 3* 3+ 3, 3- 4. 4b 4c 4d 4e 4M 5%$5w@y@0y@y@p}@ 6&$6s@p@ q@q@v@ 8f 8g 9* 9+ 9, 9- :. :h :i :j :k :M ;%$;z@|@P}@|@ @ <&$<0q@q@d@`g@0t@ >r >s ?* ?+ ?, ?-:8T668T668T668T668T66@A@B DE FGH IJK LMNOP Q@RS TUVWX YZ[ \]^_ @. @t @u @v @w @x A%$Ax@y@y@ z@~@ B&$B`i@h@j@i@p@ D DD Ez E E F. F{ F| F Fx G%$Gy@|@~@ H&$H@k@@n@p@I J JJJ K* K+ K, K-K L. L} L~ L L Lx M$M@g@g@d@c@g@ N$Nn@p@n@n@p@ O$OA@B@E@H@@S@ P&$Pm@r@s@t@v@Q R RRR S* S+ S, S-S T. T T T T Tx U$U`c@c@c@ b@e@ V$V`m@l@l@i@o@ W$WQ@S@@W@Y@ `@ X&$Xs@s@ u@`t@w@Y Z ZZZ [* [+ [, [-[ \. \ \ \ \ \x ]$]a@ b@`@ `@d@ ^$^j@i@`g@f@l@ _$_]@_@`@@a@e@BXT66&*F66 0BT6666 0BT6666 0BT66` bc defgh jk lmnop s `&$`t@0u@s@r@ x@ b bb c* c+ c, c- d. d d d d dx e$e``@_@]@@]@a@ f$ff@e@e@d@@h@ g$ga@`b@b@@d@ i@ h&$hs@0t@t@s@w@ j jj k* k+ k, k- l. l l l l lx mm `@ d@d@m~ m `@ nnr@q@p@n~ nr@ oo1@.@?o~ o1@ p&ps@s@s@p~ ps@ s$,6&8T6666&8TBBBBPH0 0(   >c@vvv ggD G    dMbP?_*+%&ffffff?'ffffff?(?)?MOMS-CT4APRRCMP5054-1  odXX10DR7f SxxuSr! ?!4iсG##>7N@E+ Ƀ ,CH w/;XjD@ B2PН72*ʌ#Α,qJMLXSH=oxb@=o (g 3lDC!g 4pzgG$v5b[pi!4h)!0t:jʋG)Q}u@-TwJ#F~?>]B(]o)^̼PX} К׮fJbsQh%١^# \uߦ5#nry$}dKGWk*Fe8[L8)جabOS0յnA u'-"72kE`b"bۋe+QЦ庌rsRy-ٺuUWE\_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn"NXX333333?333333?&<3U} } } U} } } q} } } } } q}  \  $     ]  s    t       uvd_TY5@w(\@xEz@~ xqK A y~ z {|Wϊ3@~ }@~-@?б@l@  r@~ @ ~  ~ @bn\@<(   : N(z X?\oB]4:@ ?`Q$xNL M\  < 5B 0-100%<  ; Nz X?\']4;@ 7?R)-D9W+  < 5B 101-250%<  < Nz X?\a ?]4<@ f:M*^NAzr' <Algorithm/full ben<: Thomas, Tara; Thomas, Tara < Thomas, Tara>@dmadja 7ggD G   dMbP?_*+% Page &P&?'?(?)?MOMS-CT4APRRCMP5054-1  odXX10DRWd ]JxuSAr0 =ĝ&m DBӿdˍ]-gWXrU8^vPgABo}=g4j&@AwvȄ(3;GB *59_3ۊ4Y#p4URcbBIK9W?Bp0L0F4r@wxMb:`W#&--jQ2J?A A硣H$8EWOA{ǽ4b4ץ,?r̋%hּ4Sgm,EAآfe6.(׈ k{ےfmY_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn"dXX??&U} +} }  } qNColumn A      W X Y X X Z_`b@ LL`=@`]@ Z_0@`@`*@ Z_@p@``@`_@ Z_M@`>@`=@ Z_U@`*@`@R@ Z_l@ `N@` e@ Z _[@  _7@_U@ Z _  __ Z _3@  _@_,@ Z _D@  _$@_?@ Z  _1@ `@`,@ Z _@Q@_?@_C@ Z_f@`F@`a@ Zy_@__@ Z _``@`M@`@R@ Z _@``@ Z _F@`@`D@ Z_M@`?`L@ Z_`` Z_<@_@`5@ Z__` Z_3@`@`*@ Z_``#@ %E#|@ %E#@ %E~ a@2@:8\CCCCCCCCCCCCCCCCCCC*CCu$ @2  >@qN7ggD G  #"&  dMbP?_*+%&?'?(?)?MOMS-CT4APRRCMP5054-1  odXX10DRWd ]JxuSAr0 =ĝ&m DBӿdˍ]-gWXrU8^vPgABo}=g4j&@AwvȄ(3;GB *59_3ۊ4Y#p4URcbBIK9W?Bp0L0F4r@wxMb:`W#&--jQ2J?A A硣H$8EWOA{ǽ4b4ץ,?r̋%hּ4Sgm,EAآfe6.(׈ k{ےfmY_EQG`HHYMp|_1-@YT:Ic)ѵxvv{:8LxR{6_1jLD HPځzL5M/h߱H3`ߎW'W QvoizFw"Ęsvi|Ov+)6=1ą+0gDn"dXX??&U} U} } }   [ \ \ \ \ Z!Z@ DD^Pz@^@ Z!Zd@ DD^?@^`@ Z!Z? DD^?Z Z!ZS@ DD^ @ZQ@~ a@2@x8IIII @2 PHP0(  >@7ggD Oh+'0@Hd x Bourget, Nicholas Bean, Emily@(-_}@`@`՜.+,0@HP X`hp x   enclosure 1 enclosure 2 enclosure 3 enclosure 4 enclosure 5 enclosure 6Contact_Data_R1_Crosstab  Worksheets Named Ranges  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FWorkbook'SummaryInformation(DocumentSummaryInformation8